Despite significant investment and talent, India's academic research faces a paradox: it rarely translates into market ...

India's pharma and healthcare sectors saw $3.5 bn in deals in Q3 2025, a 166% surge led by consolidation in pharma, biotech, and hospital segments ...

Union Health Minister JP Nadda recently highlighted a major transformation in India's medical education landscape, announcing ...

Sachidanand Upadhyay, Managing Director of Lord's Mark Industries Ltd. (LMIL), has achieved a significant milestone with his ...

Led by Torrent Pharma’s $1.4 billion acquisition of 46% stake in JB Chemicals & Pharmaceuticals, the July-September quarter of the current year saw a total of 72 transactions valued at $ 3.5 billion, ...

Thermo Fisher Scientific’s expanded Research and Development (R&D) Centre of Excellence has been officially inaugurated here, the company said on Tuesday. The facility, dedicated to pioneering ...

This included three IPOs worth $428 million and one QIP worth $88 million, Grant Thornton Bharat said in a statement.

New Delhi: The pharma and healthcare sector in India witnessed robust deal momentum valued at $3.5 billion in Q3 2025, ...

India's pharma and healthcare sector recorded $3.5 billion in Q3 2025, driven by 72 transactions, says Grant Thornton Bharat.

The order was passed by a bench headed by Justice M. Nagaprasanna, which also issued notices to the state government, the ...

Indian pharma and healthcare sector saw USD 3.5 billion in deals in Q3 2025, says Grant Thornton Bharat. M&A surged, PE ...

Lalu Prasad Yadav and Rabri Devi sought four weeks to prepare for cross-examination of witnesses in the IRCTC scam case; ...